| Autor: |
DIAN AYU JUWITA, YONANDA AINUL QALBI, NAJMIATUL FITRIA |
| Rok vydání: |
2023 |
| Předmět: |
|
| Zdroj: |
International Journal of Applied Pharmaceutics. :24-28 |
| ISSN: |
0975-7058 |
| DOI: |
10.22159/ijap.2023.v15s1.47502 |
| Popis: |
Objective: Human Immunodeficiency Virus (HIV) that causes acquired immunodeficiency syndrome (AIDS) remains a health problem in the world, including in Indonesia, with increasing residents of people living with HIV/AIDS every year. Viral load measurement is a better predictor than clinical or immunological measures to evaluate the success or failure of ART. This study aimed to fig. out the sociodemographic characteristics and the relationship between the duration of antiretroviral therapy and viral load in HIV/AIDS patients. Methods: A descriptive and analytic study with a retrospective approach was getting through in this research. There were 61 patients included in this study. Results: As many as 86.89% of men reported having HIV infection. The biggest risk transmission factor through sexual intercourse by 100%. The most commonly used antiretroviral treatment is TDF+FTC+EFV (Tenofovir+Emtricitabine+Efavirenz) by 50,82%. There were 17 patients and 44 with detectable and undetectable results, respectively (p 0.05). Conclusion: A statistical analysis of the duration of antiretroviral therapy and viral load concluded that the viral load decreases until it is undetectable with the longer use of ART. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
